{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/common-sources-design-flaws-clinical-trials-protocols#webpage",
"url": "https://www.fortrea.com/insights/common-sources-design-flaws-clinical-trials-protocols",
"name": "Common sources of design flaws in clinical trials protocols",
"description": "This Fortrea info sheet highlights clinical trial protocol design strategies focused on reducing design flaws and strengthening operational feasibility across clinical development programs. The publication discusses protocol optimization approaches related to clinical development planning, endpoint selection, patient burden reduction, eligibility criteria evaluation, and operational alignment within complex clinical trials. The publication also highlights challenges associated with protocol complexity, recruitment barriers, protocol amendments, inconsistent study execution, and operational inefficiencies that can affect clinical trial timelines and study performance. Fortrea supports sponsors through structured protocol development strategies designed to improve study design quality, strengthen operational feasibility, and support more efficient clinical trial execution throughout the development lifecycle. By integrating clinical trial protocol design with operational planning and patient-centered study considerations, Fortrea supports stronger protocol performance and more effective clinical development outcomes across global clinical trial programs."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Common sources of design flaws in clinical trials protocols",
"item": "https://www.fortrea.com/insights/common-sources-design-flaws-clinical-trials-protocols"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/common-sources-design-flaws-clinical-trials-protocols#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/common-sources-design-flaws-clinical-trials-protocols#webpage"
},
"headline": "Reducing Design Flaws in Clinical Trial Protocols Through Better Development Planning | Fortrea Info Sheet",
"description": "This Fortrea info sheet highlights clinical trial protocol design strategies focused on reducing design flaws and strengthening operational feasibility across clinical development programs. The publication discusses protocol optimization approaches related to clinical development planning, endpoint selection, patient burden reduction, eligibility criteria evaluation, and operational alignment within complex clinical trials. The publication also highlights challenges associated with protocol complexity, recruitment barriers, protocol amendments, inconsistent study execution, and operational inefficiencies that can affect clinical trial timelines and study performance. Fortrea supports sponsors through structured protocol development strategies designed to improve study design quality, strengthen operational feasibility, and support more efficient clinical trial execution throughout the development lifecycle. By integrating clinical trial protocol design with operational planning and patient-centered study considerations, Fortrea supports stronger protocol performance and more effective clinical development outcomes across global clinical trial programs.",
"genre": "Info Sheet",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-09/design-flaws-clinical-trials-protocols.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-09-04",
"dateModified": "2025-09-04",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-09/design-flaws-in-clinical-trials-protocols.pdf",
"encodingFormat": "application/pdf"
}
}
]
}